Alliancebernstein L.P. Ptc Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 222,048 shares of PTCT stock, worth $9.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,048

Previous 95,650 132.15%

Holding current value

$9.76 Million

Previous $2.92 Million 181.7%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $3.84 Million - $4.76 Million	126,398 Added 132.15%	222,048 $8.24 Million
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $6.53 Million - $10.6 Million	-264,507 Reduced 73.44%	95,650 $2.92 Million
Q1 2024 May 14, 2024	BUY	$24.15 - $31.95 $159,534 - $211,061	6,606 Added 1.87%	360,157 $10.5 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $4.02 Million - $6.53 Million	222,483 Added 169.75%	353,551 $9.74 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $92,530 - $173,376	-4,129 Reduced 3.05%	131,068 $2.94 Million
Q2 2023 Aug 15, 2023	SELL	$40.4 - $59.1 $7.66 Million - $11.2 Million	-189,703 Reduced 58.39%	135,197 $5.5 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $897,675 - $1.15 Million	-23,524 Reduced 6.75%	324,900 $15.7 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $7.5 Million - $12.2 Million	223,554 Added 179.03%	348,424 $13.3 Million
Q3 2022 Nov 15, 2022	BUY	$41.85 - $53.85 $1.35 Million - $1.74 Million	32,320 Added 34.92%	124,870 $6.27 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $6,666 - $8,920	200 Added 0.22%	92,550 $3.45 Million
Q3 2021 Nov 10, 2021	SELL	$37.01 - $44.74 $22,206 - $26,844	-600 Reduced 0.65%	92,350 $3.44 Million
Q2 2021 Jul 30, 2021	SELL	$37.95 - $49.37 $61.6 Million - $80.2 Million	-1,623,987 Reduced 94.59%	92,950 $3.93 Million
Q1 2021 May 06, 2021	SELL	$46.8 - $68.92 $2.64 Million - $3.89 Million	-56,430 Reduced 3.18%	1,716,937 $81.3 Million
Q4 2020 Feb 08, 2021	BUY	$47.96 - $67.64 $1.66 Million - $2.35 Million	34,709 Added 2.0%	1,773,367 $108 Million
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $3.4 Million - $4.27 Million	74,858 Added 4.5%	1,738,658 $81.3 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $2.68 Million - $3.46 Million	62,913 Added 3.93%	1,663,800 $84.4 Million
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $49.2 Million - $90.2 Million	1,519,037 Added 1855.88%	1,600,887 $71.4 Million
Q4 2019 Feb 18, 2020	BUY	$32.22 - $50.07 $90,216 - $140,196	2,800 Added 3.54%	81,850 $3.93 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $37,202 - $52,987	1,100 Added 1.41%	79,050 $2.67 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $701,316 - $891,000	19,800 Added 34.05%	77,950 $3.51 Million
Q1 2019 May 14, 2019	SELL	$28.09 - $39.49 $1.51 Million - $2.12 Million	-53,800 Reduced 48.06%	58,150 $2.19 Million
Q4 2018 Feb 13, 2019	BUY	$29.83 - $46.51 $1.24 Million - $1.93 Million	41,600 Added 59.13%	111,950 $3.84 Million
Q2 2018 Aug 13, 2018	BUY	$25.7 - $47.88 $539,700 - $1.01 Million	21,000 Added 42.55%	70,350 $2.37 Million
Q3 2017 Nov 13, 2017	BUY	$16.81 - $21.61 $829,573 - $1.07 Million	49,350	49,350 $987,000

Others Institutions Holding PTCT

# of Institutions

220

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.14B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Ptc Therapeutics, Inc. Transaction History